L04AA Selective immunosuppressants
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04AA Selective immunosuppressants
Medicines by ATC code L04AA Selective immunosuppressants
- Mavenclad Patient leaflet Summary of medicine characteristics
- Fingolimod Accord Patient leaflet Summary of medicine characteristics
- Myclausen Patient leaflet Summary of medicine characteristics
- CellCept Patient leaflet Summary of medicine characteristics
- Myfenax Patient leaflet Summary of medicine characteristics
- Mycophenolate mofetil Teva Patient leaflet Summary of medicine characteristics
- Entyvio Patient leaflet Summary of medicine characteristics
- Saphnelo Patient leaflet Summary of medicine characteristics
- Orencia Patient leaflet Summary of medicine characteristics
- Rinvoq Patient leaflet Summary of medicine characteristics
- Ocrevus Patient leaflet Summary of medicine characteristics
- Aubagio Patient leaflet Summary of medicine characteristics
- Lemtrada Patient leaflet Summary of medicine characteristics
- Jyseleca Patient leaflet Summary of medicine characteristics
- Zeposia Patient leaflet Summary of medicine characteristics
- Arava Patient leaflet Summary of medicine characteristics
- Xeljanz Patient leaflet Summary of medicine characteristics
- Gilenya Patient leaflet Summary of medicine characteristics
- Ultomiris Patient leaflet Summary of medicine characteristics
- Rapamune Patient leaflet Summary of medicine characteristics
- Olumiant Patient leaflet Summary of medicine characteristics
- Benlysta Patient leaflet Summary of medicine characteristics
- Tysabri Patient leaflet Summary of medicine characteristics
- Otezla Patient leaflet Summary of medicine characteristics
- Leflunomide ratiopharm Patient leaflet Summary of medicine characteristics
- Soliris Patient leaflet Summary of medicine characteristics
- Fingolimod Mylan Patient leaflet Summary of medicine characteristics
- Idefirix Patient leaflet Summary of medicine characteristics
- Leflunomide Zentiva (previously Leflunomide Winthrop) Patient leaflet Summary of medicine characteristics
- Kesimpta Patient leaflet Summary of medicine characteristics
- Nulojix Patient leaflet Summary of medicine characteristics
- Ponvory Patient leaflet Summary of medicine characteristics
- Leflunomide medac Patient leaflet Summary of medicine characteristics
- Repso Patient leaflet Summary of medicine characteristics
- Leflunomide Teva Patient leaflet Summary of medicine characteristics
- Raptiva Patient leaflet Summary of medicine characteristics
Other names of the ATC group
- Czech: L04AA Selektivní imunomodulátory/-supresiva
- French: L04AA immunosuppresseurs sélectifs
- German: L04AA Selektive Immunsuppressiva
- Spanish: L04AA INMUNOSUPRESORES SELECTIVOS
- German: L04AA Selektive Immunsuppressiva
- Italian: L04AA Immunosoppressori ad azione selettiva
- Polish: L04AA Selektywne immunomodulatory / supresanty
- Turkish: L04AA seçici immünosupresanlar
- Portuguese (Brazil): L04AA Imunossupressores selectivos